Bristol-Myers Squibb | BMY - Ativo Circulante





Ativo Circulante Alterar Data
AbbVie USD 33.53B 4.47B 2026-03
Abbott USD 25.51B 488M 2026-03
ALKERMES USD 1.52B 164.26M 2026-06
Amgen USD 31.48B 2.42B 2026-03
AstraZeneca USD 27.97B 1.65B 2026-06
Biogen USD 7.31B 1.88B 2026-06
Bristol-Myers Squibb USD 28.58B 1.37B 2026-06
Coherus Biosciences USD 206.71M 254.25M 2025-12
Drreddys Laboratories INR 301.98B 298.66B 2026-03
Eli Lilly USD 54.84B 794M 2026-03
Gilead Sciences USD 18.64B 1.25B 2026-03
GlaxoSmithKline GBP 17.56B 202M 2026-06
J&J USD 59.77B 601M 2026-06
Medtronic USD 24.07B 75M 2025-12
Merck USD 35.02B 8.5B 2026-03
Novartis USD 27.35B 744M 2026-06
Novo Nordisk DKK 177.32B 4.86B 2026-03
Perrigo USD 2.71B 85M 2026-03
Pfizer USD 42.82B 76M 2026-03
Phibro Animal Health USD 894.07M 31.88M 2026-03
Prestige Brands USD 431.48M 1.94M 2026-03
Regeneron Pharmaceuticals USD 18.45B 236.8M 2026-06
Roche Holding CHF 35.44B 3.29B 2026-06
Sanofi EUR 31.52B 1.36B 2026-06
Sanofi EUR 30.16B 789M 2026-03
United Therapeutics USD 2.87B 830.5M 2026-03
Zoetis USD 6.47B 294M 2026-03